DENGUE
Clinical trials for DENGUE explained in plain language.
Never miss a new study
Get alerted when new DENGUE trials appear
Sign up with your email to follow new studies for DENGUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Dengue vaccine trial expands to seniors: is it safe and effective?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a dengue vaccine in healthy adults aged 60 to 79 and compares their immune response and safety to adults aged 40 to 59. About 997 participants will receive one dose of the Butantan dengue vaccine. The goal is to see if the vaccine works as well in older adults as…
Matched conditions: DENGUE
Phase: PHASE3 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:46 UTC
-
New dengue pill aims to knock out fever faster
Disease control Recruiting nowThis study tests an experimental drug called EYU688 in 108 adults with dengue fever. The goal is to see if it can lower the amount of virus in the blood and help fever go away sooner compared to a placebo. Participants must have had a fever for 48 hours or less and test positive …
Matched conditions: DENGUE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New dengue drug trial aims to knock out virus faster
Disease control Recruiting nowThis study tests experimental antiviral drugs in people with early dengue fever (less than 48 hours of symptoms). About 500 participants will receive either an experimental drug or standard care to see if the drug can clear the virus faster and reduce complications. The goal is t…
Matched conditions: DENGUE
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New dengue drug trial aims to shorten illness
Disease control Recruiting nowThis study tests a new medicine called CP-COV03 for people with dengue fever. The goal is to see if it is safe and can help reduce symptoms and lower the amount of virus in the blood. About 210 adults with dengue will take the drug or a placebo. The trial is currently recruiting …
Matched conditions: DENGUE
Phase: PHASE2, PHASE3 • Sponsor: Hyundai Bioscience Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Massive health survey aims to uncover hidden disease threats in cambodia
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for antibodies against 57 different infectious diseases, including dengue, flu, and malaria. The goal is to learn how these diseases spread in communities and which ones are most common. This information will help health officials de…
Matched conditions: DENGUE
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated May 26, 2026 05:52 UTC
-
Dengue danger decoded: new study tracks hospitalization triggers
Knowledge-focused Recruiting nowThis study follows 100 people with confirmed dengue to learn which signs and lab results predict the need for hospital care. Researchers also track how often blood transfusions are given and what happens afterward. The goal is to help doctors make better decisions about who needs…
Matched conditions: DENGUE
Sponsor: Jose Ivan Rodriguez de Molina Serrano • Aim: Knowledge-focused
Last updated May 26, 2026 05:47 UTC
-
Scientists to infect volunteers with dengue in quest for better vaccines
Knowledge-focused Recruiting nowThis study will give 5 healthy adults in Singapore a weakened form of the dengue virus to safely create a mild infection. Researchers will closely monitor how the virus behaves and how the immune system responds. The goal is to build a reliable model for testing future dengue vac…
Matched conditions: DENGUE
Phase: NA • Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC